WGCNA highlighted a strong correlation between gene expression and functional changes including ligation, hypersensitivity, and anxiety, which established the microglial GLP-1R pathway in pain management, and highlighted key elements of pain-associated targets of spinal microglial GLP-1R in future pharmaceutical development, as shown in Figure 5. This evidence concerns the gene GLP1R and Anxiety.